Transplant Volume: Zydus Hospitals Ahmedabad and Vadodara have performed over 430 kidney transplants, more than 295 liver transplants, and over 220 bone marrow transplants, bringing the combined total close to 1,000 transplants, the highest among private hospital chains in Gujarat.
Cost Structure: The hospitals charge approximately 6.5 lakhs per transplant, which is less than half of the >15 lakhs charged by other metropolitan hospitals; bone marrow transplant packages start from 4 lakhs.
Facilities: Ahmedabad hosts a 50‑bed dialysis unit, one of the region’s largest, complemented by a dedicated renal dialysis unit in Vadodara staffed round‑the‑clock.
Liver Transplant Services: Includes ABO‑incompatible transplants and simultaneous liver‑kidney transplants (SLKT) for both paediatric and adult patients, performed using living donors or cadaveric donors under the Transplantation of Human Organs and Tissues Act (THOTA).
Bone Marrow Transplant Programme: Gujarat’s largest BMT unit with combined experience of over 1,300 transplants (200+ at Zydus Ahmedabad) covering adult and paediatric blood cancers, haematological disorders, stem‑cell therapy, inborn errors of immunity, bone‑marrow failure syndromes, and CAR‑T cell therapy.
Cardiac Transplant Capability: The hospital also performs cardiac transplants for end‑stage heart‑failure patients, supported by CVTS specialists, cardiologists, perfusionists, intensivists, and anaesthetists.
Organ Donation Context: India’s deceased donor rate is below one donor per million population; a single organ donor can potentially save up to eight lives, underscoring the need for increased public awareness and family consent.
Strategic Positioning: The integrated multidisciplinary ecosystem has attracted patients from across India and abroad, positioning Zydus Hospitals as a trusted transplant destination in the region.
Stock Market Impact: The strong transplant volumes, affordable pricing, and expanded service portfolio may boost investor confidence in Zydus Hospitals and the broader private healthcare sector in Gujarat.
Listed Companies and Sectors: The announcement could positively influence the valuation of listed hospital operators, medical equipment manufacturers, and pharmaceutical firms linked to transplant care.
Investment Flows: Demonstrated demand and cost‑competitiveness may encourage domestic and foreign capital inflows into Gujarat’s private healthcare infrastructure.
Interest Rates, Inflation, Liquidity: No direct references in the release.
Fiscal or Monetary Policy: No policy measures are mentioned.
